Search Results 251-260 of 17300 for Proto-oncogene
... oncogenic signaling. Preclinical studies demonstrated that GIPCi significantly suppressed tumor growth, enhanced the efficacy of gemcitabine, remodeled the ...
Learn about symptoms, diagnosis and treatment of these growths that occur in and around the ovaries and fallopian tubes.
A recent Mayo Clinic study demonstrated that endoscopic ultrasound-acquired cytology-based tumor genotyping can reveal a spectrum of genetic variants, ...
The overall objective of this research is to evaluate and define the molecular and biological characteristics of CTCs from advanced solid tumor patients who ...
Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
Survivors of childhood brain cancers who undergo radiation therapy can have damage to normal brain tissue. Activities such as attention training and physical ...
Drugs used in chemotherapy, such as cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or stopping them from ...
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
Learn about the training opportunities available in Dr. Rodriguez-Bravo's Genome Function, Stability and Nuclear Organization in Cancer at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.